APO RESEARCH · REPORT
New Medical Materials and Biomaterials
New Medical Materials and Biomaterials is newly developed materials for medical devices, tools, and other things (excluding drugs).
Product & engineering
Understand the product.
New Medical Materials and Biomaterials is newly developed materials for medical devices, tools, and other things (excluding drugs).
Selected research
Market Structure
Global New Medical Materials and Biomaterials Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
New Medical Materials and Biomaterials is newly developed materials for medical devices, tools, and other things (excluding drugs).
In US, New Medical Materials and Biomaterials key players include STR, Avitus, Sagemax, Stratasys, Formlab, etc.
In terms of product, Bioceramics is the largest segment, with a share over 20%. And in terms of application, the largest application is Catheters, followed by Dental Products, Transplant Components, etc.
Read the full market overview
Report Includes
This report provides an overview of the global New Medical Materials and Biomaterials market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of New Medical Materials and Biomaterials and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents New Medical Materials and Biomaterials revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the New Medical Materials and Biomaterials market size, projected growth trends, production technologies, key applications, and end-use industries.
New Medical Materials and Biomaterials Segment by Company
STR
Avitus
Sagemax
Stratasys
Formlab
NanoH2O (LG)
Covalent-coating
Nasseo
TriboFilm
ACS material
Palmaz Scientific
Invibio
Secant Medical
TeraPore Technologies
New Medical Materials and Biomaterials Segment by Type
Medical Polymers
Bioceramics
Medical 3D Printing Materials
Membranes
Surface Modifications
Others
New Medical Materials and Biomaterials Segment by Application
Packaging
Transplant Components
Dental Products
Catheters
Others
New Medical Materials and Biomaterials Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global New Medical Materials and Biomaterials market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of New Medical Materials and Biomaterials and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of New Medical Materials and Biomaterials.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of New Medical Materials and Biomaterials in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global New Medical Materials and Biomaterials industry.
Chapter 3: Detailed analysis of New Medical Materials and Biomaterials companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, New Medical Materials and Biomaterialsrevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Medical Polymers
- Bioceramics
- Medical 3D Printing Materials
- Membranes
- Surface Modifications
- Others
Applications
- Packaging
- Transplant Components
- Dental Products
- Catheters
- Others
Companies covered
- STR
- Avitus
- Sagemax
- Stratasys
- Formlab
- NanoH2O (LG)
- Covalent-coating
- Nasseo
- TriboFilm
- ACS material
- Palmaz Scientific
- Invibio
- Secant Medical
- TeraPore Technologies
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global New Medical Materials and Biomaterials Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 Medical Polymers
- 1.2.3 Bioceramics
- 1.2.4 Medical 3D Printing Materials
- 1.2.5 Membranes
- 1.2.6 Surface Modifications
- 1.2.7 Others
- 1.3 Market Analysis by Application
- 1.3.1 Global New Medical Materials and Biomaterials Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Packaging
- 1.3.3 Transplant Components
- 1.3.4 Dental Products
- 1.3.5 Catheters
- 1.3.6 Others
- 1.4 Global Market Growth Prospects
- 1.5 Global New Medical Materials and Biomaterials Growth Trends by Region
- 1.5.1 Global New Medical Materials and Biomaterials Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 New Medical Materials and Biomaterials Market Size by Region (2021-2026)
- 1.5.3 New Medical Materials and Biomaterials Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global New Medical Materials and Biomaterials Market Dynamics
- 2.1 New Medical Materials and Biomaterials Industry Trends
- 2.2 New Medical Materials and Biomaterials Industry Drivers
- 2.3 New Medical Materials and Biomaterials Industry Opportunities and Challenges
- 2.4 New Medical Materials and Biomaterials Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global New Medical Materials and Biomaterials Revenue by Company (2021-2026)
- 3.2 Global New Medical Materials and Biomaterials Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global New Medical Materials and Biomaterials Key Company Head office and Area Served
- 3.4 Global New Medical Materials and Biomaterials Company, Product Type & Application
- 3.5 Global New Medical Materials and Biomaterials Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global New Medical Materials and Biomaterials Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 New Medical Materials and Biomaterials Players Market Share by Revenue in 2025
- 3.6.3 2025 New Medical Materials and Biomaterials Tier 1, Tier 2, and Tier 3
4 New Medical Materials and Biomaterials Market by Type
- 4.1 Global New Medical Materials and Biomaterials Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global New Medical Materials and Biomaterials Market Size by Type (2021-2032)
- 4.3 Global New Medical Materials and Biomaterials Market Size Share by Type (2021-2032)
5 New Medical Materials and Biomaterials Market by Application
- 5.1 Global New Medical Materials and Biomaterials Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global New Medical Materials and Biomaterials Market Size by Application (2021-2032)
- 5.3 Global New Medical Materials and Biomaterials Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 STR
- 6.1.1 STR Company Information
- 6.1.2 STR Business Overview
- 6.1.3 STR New Medical Materials and Biomaterials Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 STR New Medical Materials and Biomaterials Product Portfolio
- 6.1.5 STR Recent Developments
- 6.2 Avitus
- 6.2.1 Avitus Company Information
- 6.2.2 Avitus Business Overview
- 6.2.3 Avitus New Medical Materials and Biomaterials Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 Avitus New Medical Materials and Biomaterials Product Portfolio
- 6.2.5 Avitus Recent Developments
- 6.3 Sagemax
- 6.3.1 Sagemax Company Information
- 6.3.2 Sagemax Business Overview
- 6.3.3 Sagemax New Medical Materials and Biomaterials Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 Sagemax New Medical Materials and Biomaterials Product Portfolio
- 6.3.5 Sagemax Recent Developments
- 6.4 Stratasys
- 6.4.1 Stratasys Company Information
- 6.4.2 Stratasys Business Overview
- 6.4.3 Stratasys New Medical Materials and Biomaterials Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 Stratasys New Medical Materials and Biomaterials Product Portfolio
- 6.4.5 Stratasys Recent Developments
- 6.5 Formlab
- 6.5.1 Formlab Company Information
- 6.5.2 Formlab Business Overview
- 6.5.3 Formlab New Medical Materials and Biomaterials Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 Formlab New Medical Materials and Biomaterials Product Portfolio
- 6.5.5 Formlab Recent Developments
- 6.6 NanoH2O (LG)
- 6.6.1 NanoH2O (LG) Company Information
- 6.6.2 NanoH2O (LG) Business Overview
- 6.6.3 NanoH2O (LG) New Medical Materials and Biomaterials Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 NanoH2O (LG) New Medical Materials and Biomaterials Product Portfolio
- 6.6.5 NanoH2O (LG) Recent Developments
- 6.7 Covalent-coating
- 6.7.1 Covalent-coating Company Information
- 6.7.2 Covalent-coating Business Overview
- 6.7.3 Covalent-coating New Medical Materials and Biomaterials Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 Covalent-coating New Medical Materials and Biomaterials Product Portfolio
- 6.7.5 Covalent-coating Recent Developments
- 6.8 Nasseo
- 6.8.1 Nasseo Company Information
- 6.8.2 Nasseo Business Overview
- 6.8.3 Nasseo New Medical Materials and Biomaterials Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 Nasseo New Medical Materials and Biomaterials Product Portfolio
- 6.8.5 Nasseo Recent Developments
- 6.9 TriboFilm
- 6.9.1 TriboFilm Company Information
- 6.9.2 TriboFilm Business Overview
- 6.9.3 TriboFilm New Medical Materials and Biomaterials Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 TriboFilm New Medical Materials and Biomaterials Product Portfolio
- 6.9.5 TriboFilm Recent Developments
- 6.10 ACS material
- 6.10.1 ACS material Company Information
- 6.10.2 ACS material Business Overview
- 6.10.3 ACS material New Medical Materials and Biomaterials Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.10.4 ACS material New Medical Materials and Biomaterials Product Portfolio
- 6.10.5 ACS material Recent Developments
- 6.11 Palmaz Scientific
- 6.11.1 Palmaz Scientific Company Information
- 6.11.2 Palmaz Scientific Business Overview
- 6.11.3 Palmaz Scientific New Medical Materials and Biomaterials Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.11.4 Palmaz Scientific New Medical Materials and Biomaterials Product Portfolio
- 6.11.5 Palmaz Scientific Recent Developments
- 6.12 Invibio
- 6.12.1 Invibio Company Information
- 6.12.2 Invibio Business Overview
- 6.12.3 Invibio New Medical Materials and Biomaterials Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.12.4 Invibio New Medical Materials and Biomaterials Product Portfolio
- 6.12.5 Invibio Recent Developments
- 6.13 Secant Medical
- 6.13.1 Secant Medical Company Information
- 6.13.2 Secant Medical Business Overview
- 6.13.3 Secant Medical New Medical Materials and Biomaterials Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.13.4 Secant Medical New Medical Materials and Biomaterials Product Portfolio
- 6.13.5 Secant Medical Recent Developments
- 6.14 TeraPore Technologies
- 6.14.1 TeraPore Technologies Company Information
- 6.14.2 TeraPore Technologies Business Overview
- 6.14.3 TeraPore Technologies New Medical Materials and Biomaterials Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.14.4 TeraPore Technologies New Medical Materials and Biomaterials Product Portfolio
- 6.14.5 TeraPore Technologies Recent Developments
7 North America
- 7.1 North America New Medical Materials and Biomaterials Market Size (2021-2032)
- 7.2 North America New Medical Materials and Biomaterials Market Size by Type
- 7.2.1 North America New Medical Materials and Biomaterials Market Size by Type (2021-2026)
- 7.2.2 North America New Medical Materials and Biomaterials Market Size by Type (2027-2032)
- 7.2.3 North America New Medical Materials and Biomaterials Market Share by Type (2021-2032)
- 7.3 North America New Medical Materials and Biomaterials Market Size by Application
- 7.3.1 North America New Medical Materials and Biomaterials Market Size by Application (2021-2026)
- 7.3.2 North America New Medical Materials and Biomaterials Market Size by Application (2027-2032)
- 7.3.3 North America New Medical Materials and Biomaterials Market Share by Application (2021-2032)
- 7.4 North America New Medical Materials and Biomaterials Market Size by Country
- 7.4.1 North America New Medical Materials and Biomaterials Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America New Medical Materials and Biomaterials Market Size by Country (2021-2026)
- 7.4.3 North America New Medical Materials and Biomaterials Market Size by Country (2027-2032)
- 7.4.4 North America New Medical Materials and Biomaterials Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe New Medical Materials and Biomaterials Market Size (2021-2032)
- 8.2 Europe New Medical Materials and Biomaterials Market Size by Type
- 8.2.1 Europe New Medical Materials and Biomaterials Market Size by Type (2021-2026)
- 8.2.2 Europe New Medical Materials and Biomaterials Market Size by Type (2027-2032)
- 8.2.3 Europe New Medical Materials and Biomaterials Market Share by Type (2021-2032)
- 8.3 Europe New Medical Materials and Biomaterials Market Size by Application
- 8.3.1 Europe New Medical Materials and Biomaterials Market Size by Application (2021-2026)
- 8.3.2 Europe New Medical Materials and Biomaterials Market Size by Application (2027-2032)
- 8.3.3 Europe New Medical Materials and Biomaterials Market Share by Application (2021-2032)
- 8.4 Europe New Medical Materials and Biomaterials Market Size by Country
- 8.4.1 Europe New Medical Materials and Biomaterials Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe New Medical Materials and Biomaterials Market Size by Country (2021-2026)
- 8.4.3 Europe New Medical Materials and Biomaterials Market Size by Country (2027-2032)
- 8.4.4 Europe New Medical Materials and Biomaterials Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China New Medical Materials and Biomaterials Market Size (2021-2032)
- 9.2 China New Medical Materials and Biomaterials Market Size by Type
- 9.2.1 China New Medical Materials and Biomaterials Market Size by Type (2021-2026)
- 9.2.2 China New Medical Materials and Biomaterials Market Size by Type (2027-2032)
- 9.2.3 China New Medical Materials and Biomaterials Market Share by Type (2021-2032)
- 9.3 China New Medical Materials and Biomaterials Market Size by Application
- 9.3.1 China New Medical Materials and Biomaterials Market Size by Application (2021-2026)
- 9.3.2 China New Medical Materials and Biomaterials Market Size by Application (2027-2032)
- 9.3.3 China New Medical Materials and Biomaterials Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia New Medical Materials and Biomaterials Market Size (2021-2032)
- 10.2 Asia New Medical Materials and Biomaterials Market Size by Type
- 10.2.1 Asia New Medical Materials and Biomaterials Market Size by Type (2021-2026)
- 10.2.2 Asia New Medical Materials and Biomaterials Market Size by Type (2027-2032)
- 10.2.3 Asia New Medical Materials and Biomaterials Market Share by Type (2021-2032)
- 10.3 Asia New Medical Materials and Biomaterials Market Size by Application
- 10.3.1 Asia New Medical Materials and Biomaterials Market Size by Application (2021-2026)
- 10.3.2 Asia New Medical Materials and Biomaterials Market Size by Application (2027-2032)
- 10.3.3 Asia New Medical Materials and Biomaterials Market Share by Application (2021-2032)
- 10.4 Asia New Medical Materials and Biomaterials Market Size by Country
- 10.4.1 Asia New Medical Materials and Biomaterials Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia New Medical Materials and Biomaterials Market Size by Country (2021-2026)
- 10.4.3 Asia New Medical Materials and Biomaterials Market Size by Country (2027-2032)
- 10.4.4 Asia New Medical Materials and Biomaterials Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa New Medical Materials and Biomaterials Market Size (2021-2032)
- 11.2 South America, Middle East & Africa New Medical Materials and Biomaterials Market Size by Type
- 11.2.1 South America, Middle East & Africa New Medical Materials and Biomaterials Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa New Medical Materials and Biomaterials Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa New Medical Materials and Biomaterials Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa New Medical Materials and Biomaterials Market Size by Application
- 11.3.1 South America, Middle East & Africa New Medical Materials and Biomaterials Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa New Medical Materials and Biomaterials Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa New Medical Materials and Biomaterials Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa New Medical Materials and Biomaterials Market Size by Country
- 11.4.1 South America, Middle East & Africa New Medical Materials and Biomaterials Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa New Medical Materials and Biomaterials Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa New Medical Materials and Biomaterials Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa New Medical Materials and Biomaterials Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst